🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07704229
Starting soon Observational

Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery

NCT07704229 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2026-09-01
Last updated
2026-07-16

Condition(s) studied

Obesity, Morbid

Investigational drug(s) / intervention(s)

Sleeve Gastrectomy

Sleeve Gastrectomy: Vertical sleeve gastrectomy

Study summary

Despite global efforts, the prevalence of obesity continues to rise, with rates in Canada tripling over the past three decades. In addition to the well-established risk of cardiometabolic conditions such as heart disease and diabetes, obesity has been associated with cognitive decline and an increased risk of dementia later in life. Sleeve gastrectomy, the most widely used surgical treatment for severe obesity, has proven effective in promoting significant weight loss and improving overall health. Emerging research, including our recent brain imaging study, suggests that this surgery may also have a positive impact on brain health. Our findings demonstrated significant improvements, with patients experiencing reductions in brain age by 2.9 and 5.6 years 12 and 24 months post-surgery, respectively. Despite these promising results, the long-term effects of sleeve gastrectomy on brain health and cognitive function remains poorly understood. While some patients experience cognitive improvements following surgery, others do not, and the factors driving this variability remain unknown.

This proposal aims to comprehensively investigate the impact of bariatric surgery on brain health by examining its cognitive consequences, determinants, and drivers. Understanding the key factors that contribute to brain health improvements after bariatric surgery is essential for optimizing its benefits, preventing relapse and developing personalized interventions to maintain or enhance brain health in individuals living with obesity.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Women or men between 18 and 65 years who meet the Guidelines for bariatric surgery (BM I≥ 30 kg/m2 with major comorbidities or BMI ≥ 35 kg/m2 Exclusion Criteria: * Pregnancy * Liver cirrhosis * Unstable medical, surgical or psychiatric conditions * Substance or alcohol abuse * Medications affecting the central nervous system * Previous gastric, oesophageal, brain, or bariatric surgeries * Gastrointestinal inflammatory diseases or ulcers * MRI contraindications

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval Québec Quebec

More Laval University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07704229 on ClinicalTrials.gov ↗ ← All trials in Canada